Cargando…

An adjuvanted zoster vaccine elicits potent cellular immune responses in mice without QS21

Herpes zoster (HZ) is caused by reactivation of latent varicella-zoster virus (VZV) when VZV-specific cellular immunity is insufficient to control reactivation. Currently, Shingrix, which contains the VZV gE protein and GSK’s AS01(B) adjuvant composed of liposomes formulated with cholesterol, monoph...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nam, Hyo Jung, Hong, Sung Jun, Lee, Ara, Kim, Jiyeon, Lee, Sangho, Casper, Corey, Carter, Darrick, Reed, Steven G., Simeon, George, Shin, Eui-Cheol
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9033770/ https://www.ncbi.nlm.nih.gov/pubmed/35459225 http://dx.doi.org/10.1038/s41541-022-00467-z

Ejemplares similares

QS-21: A Potent Vaccine Adjuvant
por: Zhu, Daming, et al.
Publicado: (2015)

Potent response of QS-21 as a vaccine adjuvant in the skin when delivered with the Nanopatch, resulted in adjuvant dose sparing
por: Ng, Hwee-Ing, et al.
Publicado: (2016)

Development of a minimal saponin vaccine adjuvant based on QS-21
por: Fernández-Tejada, Alberto, et al.
Publicado: (2014)

Herpes Zoster DNA Vaccines with IL-7 and IL-33 Molecular Adjuvants Elicit Protective T Cell Immunity
por: Kim, A Reum, et al.
Publicado: (2018)

Lysosome-Dependent Activation of Human Dendritic Cells by the Vaccine Adjuvant QS-21
por: Welsby, Iain, et al.
Publicado: (2017)

Ionizable Lipid Nanoparticles Enhanced the Synergistic Adjuvant Effect of CpG ODNs and QS21 in a Varicella Zoster Virus Glycoprotein E Subunit Vaccine
por: Luan, Ning, et al.
Publicado: (2022)

Meta-Analysis on Randomized Controlled Trials of Vaccines with QS-21 or ISCOMATRIX Adjuvant: Safety and Tolerability
por: Bigaeva, Emilia, et al.
Publicado: (2016)

QS-21 enhances the early antibody response to oil adjuvant foot-and-mouth disease vaccine in cattle
por: Çokçalışkan, Can, et al.
Publicado: (2016)

Development of Improved Vaccine Adjuvants Based on the Saponin Natural Product QS-21 through Chemical Synthesis
por: Fernández-Tejada, Alberto, et al.
Publicado: (2016)

Abstract QS21: Leadership In Plastic Surgery
por: Murphy, Carolyn P., et al.
Publicado: (2019)

Atomic Model and Micelle Dynamics of QS-21 Saponin
por: Pedebos, Conrado, et al.
Publicado: (2014)

Clinical Adjuvant Combinations Stimulate Potent B-Cell Responses In Vitro by Activating Dermal Dendritic Cells
por: Matthews, Katie, et al.
Publicado: (2013)

Test Of Closure Of Orbit BumPS In Qs3, Qs4, Qs5, Qs6
por: Koutchouk, Jean-Pierre, et al.
Publicado: (1991)

Anmerkung zu LG Nürnberg-Fürth, Beschl. v. 24.1.2022 – 18 Qs 24/21, 18 Qs 25/21
por: Gierok, Markus, et al.
Publicado: (2022)

Similarities and differences of chemical compositions and physical and functional properties of adjuvant system 01 and army liposome formulation with QS21
por: Alving, Carl R., et al.
Publicado: (2023)

Replacing the Rhamnose‐Xylose Moiety of QS‐21 with Simpler Terminal Disaccharide Units Attenuates Adjuvant Activity in Truncated Saponin Variants
por: Fuentes, Roberto, et al.
Publicado: (2021)

Liposome and QS-21 Combined Adjuvant Induces theHumoral and Cellular Responses of Acellular Pertussis Vaccine in a Mice Model
por: Yang, Baifeng, et al.
Publicado: (2023)

Glucopyranosyl Lipid A Adjuvant Significantly Enhances HIV Specific T and B Cell Responses Elicited by a DNA-MVA-Protein Vaccine Regimen
por: McKay, Paul F., et al.
Publicado: (2014)

Glucopyranosyl Lipid Adjuvant (GLA), a Synthetic TLR4 Agonist, Promotes Potent Systemic and Mucosal Responses to Intranasal Immunization with HIVgp140
por: Arias, Mauricio A., et al.
Publicado: (2012)

QS21-Initiated Fusion of Liposomal Small Unilamellar Vesicles to Form ALFQ Results in Concentration of Most of the Monophosphoryl Lipid A, QS21, and Cholesterol in Giant Unilamellar Vesicles
por: Abucayon, Erwin G., et al.
Publicado: (2023)

1238. The Novel Semisynthetic Saponin Adjuvant TQL1055 Enhances the Antibody Response to Pertussis Vaccine with an Improved Tolerability Profile over QS-21
por: Buzz, Chloe, et al.
Publicado: (2020)

A Comparison of Intramuscular and Subcutaneous Administration of LigA Subunit Vaccine Adjuvanted with Neutral Liposomal Formulation Containing Monophosphoryl Lipid A and QS21
por: Techawiwattanaboon, Teerasit, et al.
Publicado: (2020)

A Liquid Chromatography High-Resolution Tandem Mass Spectrometry Method to Quantify QS-21 Adjuvant and Its Degradation Products in Liposomal Drug Formulations
por: Abucayon, Erwin G., et al.
Publicado: (2023)

Inactivated vaccine with glycyrrhizic acid adjuvant elicits potent innate and adaptive immune responses against foot-and-mouth disease
por: Shin, Seokwon, et al.
Publicado: (2023)

Abstract QS21: Exome Mutations In Sun-exposed Skin And Basal Cell Carcinoma
por: Collawn, Sherry S., et al.
Publicado: (2020)

Updated insights into the mechanism of action and clinical profile of the immunoadjuvant QS-21: A review()
por: Lacaille-Dubois, Marie-Aleth
Publicado: (2019)

Healthy ageing: Herpes zoster infection and the role of the adjuvanted recombinant zoster vaccine
por: Curran, D, et al.
Publicado: (2022)

Polymeric Pathogen-Like Particles-Based Combination Adjuvants Elicit Potent Mucosal T Cell Immunity to Influenza A Virus
por: Kingstad-Bakke, Brock, et al.
Publicado: (2021)

QS version 3.0
por: Chang, Yih-Long
Publicado: (1995)

Soluble HIV-1 Env trimers in adjuvant elicit potent and diverse functional B cell responses in primates
por: Sundling, Christopher, et al.
Publicado: (2010)

Soluble HIV-1 Env trimers in adjuvant elicit potent and diverse functional B cell responses in primates
por: Sundling, Christopher, et al.
Publicado: (2010)

A Formulated TLR7/8 Agonist is a Flexible, Highly Potent and Effective Adjuvant for Pandemic Influenza Vaccines
por: Van Hoeven, Neal, et al.
Publicado: (2017)

Abstract QS42: Neo - Adjuvant Chemotherapy is Not Associated With Increased Risk of Complications in Immediate Autologous Breast Reconstruction
por: Karamanos, Efstathios, et al.
Publicado: (2018)

Central Role of CD169(+) Lymph Node Resident Macrophages in the Adjuvanticity of the QS-21 Component of AS01
por: Detienne, Sophie, et al.
Publicado: (2016)

Efficacy of the novel CDK7 inhibitor QS1189 in mantle cell lymphoma
por: Choi, Yun Jung, et al.
Publicado: (2019)

Development and Characterization of Synthetic Glucopyranosyl Lipid Adjuvant System as a Vaccine Adjuvant
por: Coler, Rhea N., et al.
Publicado: (2011)

Longitudinal displacements of the QS0's and their compensation
por: Roy, G, et al.
Publicado: (1995)

Evaluation of glycoprotein E subunit and live attenuated varicella‐zoster virus vaccines formulated with a single‐strand RNA‐based adjuvant
por: Lee, Su Jeen, et al.
Publicado: (2020)

Specificity analysis of sera from breast cancer patients vaccinated with MUC1-KLH plus QS-21
por: Adluri, S, et al.
Publicado: (1999)

Long-Term Extensions of Randomized Vaccination Trials of ACC-001 and QS-21 in Mild to Moderate Alzheimer’s Disease
por: Hüll, Michael, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_el455b9gmcqlk1ng07ltqfmtqj